These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33880499)

  • 1. MicroRNAs as biomarkers of multimodal treatment for rectal cancer.
    Waldron RM; Moloney BM; Gilligan K; Lowery AJ; Joyce MR; Holian E; Kerin MJ; Miller N
    Br J Surg; 2021 Aug; 108(8):e260-e261. PubMed ID: 33880499
    [No Abstract]   [Full Text] [Related]  

  • 2. MicroRNAs in Colon and Rectal Cancer - Novel Biomarkers from Diagnosis to Therapy.
    Yang Y; Meng WJ; Wang ZQ
    Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1211-1226. PubMed ID: 32370729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer.
    Du B; Wang X; Wu D; Wang T; Yang X; Wang J; Shi X; Chen L; Zhang W
    Mol Med Rep; 2018 Aug; 18(2):1909-1916. PubMed ID: 29956755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
    Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.
    Jo P; Azizian A; Salendo J; Kramer F; Bernhardt M; Wolff HA; Gruber J; Grade M; Beißbarth T; Ghadimi BM; Gaedcke J
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28554991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
    Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
    BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening candidate microRNA-mRNA regulatory pairs for predicting the response to chemoradiotherapy in rectal cancer by a bioinformatics approach.
    Peng Q; Zhu J; Shen P; Yao W; Lei Y; Zou L; Xu Y; Shen Y; Zhu Y
    Sci Rep; 2017 Sep; 7(1):11312. PubMed ID: 28900297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer.
    Azizian A; Epping I; Kramer F; Jo P; Bernhardt M; Kitz J; Salinas G; Wolff HA; Grade M; Beißbarth T; Ghadimi BM; Gaedcke J
    Int J Mol Sci; 2016 Apr; 17(4):568. PubMed ID: 27092493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
    Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of locally-advanced rectal adenocarcinoma using microRNA expression (Review).
    Pettit C; Walston S; Wald P; Webb A; Williams TM
    Int J Oncol; 2017 Aug; 51(2):393-404. PubMed ID: 28627602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: novel players in cancer diagnosis and therapies.
    Oom AL; Humphries BA; Yang C
    Biomed Res Int; 2014; 2014():959461. PubMed ID: 25101302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
    Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
    D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
    Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal Cancer: Time for Precision Medicine?
    Weiser MR
    Ann Surg Oncol; 2016 Jan; 23(1):12-5. PubMed ID: 26323994
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antisense microRNA targeting survivin on rectal cancer HRC-9698 cells and its mechanism.
    Dai J; Wu W; Zhou J; Gao K; Hu G; Lin C; Zhang Y; Li X
    Int J Clin Exp Pathol; 2015; 8(6):6057-63. PubMed ID: 26261483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
    Eriksen AH; Andersen RF; Pallisgaard N; Sørensen FB; Jakobsen A; Hansen TF
    PLoS One; 2016; 11(3):e0150593. PubMed ID: 26937645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D Cell Culture-Based Global miRNA Expression Analysis Reveals miR-142-5p as a Theranostic Biomarker of Rectal Cancer Following Neoadjuvant Long-Course Treatment.
    Kunigenas L; Stankevicius V; Dulskas A; Budginaite E; Alzbutas G; Stratilatovas E; Cordes N; Suziedelis K
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32316138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding and Resetting Radiation Sensitivity in Rectal Cancer.
    Kelley KA; Ruhl RA; Rana SR; Dewey E; Espinosa C; Thomas CR; Martindale RG; Anand S; Tsikitis VL
    Ann Surg; 2017 Oct; 266(4):610-616. PubMed ID: 28742699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P27 does not predict histopathological response to radiochemotherapy in rectal cancer.
    Günther K; Dimmler A; Rödel F; Reulbach U; Merkel S; Bittorf BR; Matzel KE; Papadopoulos T; Hohenberger W; Sauer R; Rödel C
    J Surg Res; 2003 Aug; 113(2):179-88. PubMed ID: 12957127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.